Market Tracker

06/23 2:56pm ET

Heron Therapeutics Inc (NASDAQ:HRTX)

14.95
BATS BZX Real-Time Price
As of 2:55pm ET
 -0.45 / -2.92%
Today’s Change
12.21
Today|||52-Week Range
24.00
+14.12%
Year-to-Date
No recent news for Heron Therapeutics Inc.

Today’s Trading

Previous close15.40
Today’s open15.60
Day’s range14.90 - 15.78
Volume19,445
Average volume (3 months)751,770
Market cap$826.9M
Dividend yield--
Data as of 2:55pm ET, 06/23/2017

Growth & Valuation

Earnings growth (last year)-54.76%
Earnings growth (this year)+18.64%
Earnings growth (next 5 years)+26.70%
Revenue growth (last year)--
P/E ratioNM
Price/Sales388.44
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CLLSCellectis SA+1.26+5.44%
ATNXAthenex Inc+0.39+2.61%
AMPHAmphastar Pharmaceut...+0.07+0.40%
RVNCRevance Therapeutics...-0.32-1.23%
Data as of 2:55pm ET, 06/23/2017

Financials

Next reporting dateAugust 7, 2017
EPS forecast (this quarter)-$0.92
Annual revenue (last year)$1.3M
Annual profit (last year)-$173.1M
Net profit margin-13,537.37%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Barry D. Quart
President, Director &
Chief Commercial Officer
Robert H. Rosen
Corporate headquarters
Redwood City, California

Forecasts